318 related articles for article (PubMed ID: 11686316)
21. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
22. [Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
Tóth O; Dávid M; Habon T; Nagy A; Keszthelyi Z; Kovács N; Losonczy H
Orv Hetil; 2005 Oct; 146(41):2121-5. PubMed ID: 16304806
[TBL] [Abstract][Full Text] [Related]
23. Molecular basis of antithrombin deficiency.
Luxembourg B; Delev D; Geisen C; Spannagl M; Krause M; Miesbach W; Heller C; Bergmann F; Schmeink U; Grossmann R; Lindhoff-Last E; Seifried E; Oldenburg J; Pavlova A
Thromb Haemost; 2011 Apr; 105(4):635-46. PubMed ID: 21264449
[TBL] [Abstract][Full Text] [Related]
24. Antithrombin deficiency in three Japanese families: one novel and two reported point mutations in the antithrombin gene.
Maruyama K; Morishita E; Karato M; Kadono T; Sekiya A; Goto Y; Sato T; Nomoto H; Omi W; Tsuzura S; Imai H; Asakura H; Ohtake S; Nakao S
Thromb Res; 2013 Aug; 132(2):e118-23. PubMed ID: 23809926
[TBL] [Abstract][Full Text] [Related]
25. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S.
De Stefano V; Simioni P; Rossi E; Tormene D; Za T; Pagnan A; Leone G
Haematologica; 2006 May; 91(5):695-8. PubMed ID: 16670075
[TBL] [Abstract][Full Text] [Related]
26. Antithrombin Cambridge II mutation as a risk factor to develop cerebral venous thrombosis.
Barba P; Santamaría A; Tirado I; Martí E; Fontcuberta J
Thromb Haemost; 2008 Feb; 99(2):443-4. PubMed ID: 18278198
[No Abstract] [Full Text] [Related]
27. Homozygous or compound heterozygous qualitative antithrombin III deficiency.
Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):335-7. PubMed ID: 7971256
[TBL] [Abstract][Full Text] [Related]
28. A heparin binding site Arg79Cys missense mutation in the SERPINC1 gene in a Korean patient with hereditary antithrombin deficiency.
Yoo JH; Maeng HY; Kim HJ; Lee KA; Choi JR; Song J
Ann Clin Lab Sci; 2011; 41(1):89-92. PubMed ID: 21325262
[TBL] [Abstract][Full Text] [Related]
29. Molecular basis and thrombotic manifestations of antithrombin deficiency in 15 unrelated Chinese patients.
Ding Q; Wang M; Xu G; Ye X; Xi X; Yu T; Wang X; Wang H
Thromb Res; 2013 Sep; 132(3):367-73. PubMed ID: 23932013
[TBL] [Abstract][Full Text] [Related]
30. Novel SERPINC1 missense mutation (Cys462Tyr) causes disruption of the 279Cys-462Cys disulfide bond and leads to type Ⅰ hereditary antithrombin deficiency.
Zhang F; Gui Y; Lu Y; Liu D; Chen H; Qin X; Li S
Clin Biochem; 2020 Nov; 85():38-42. PubMed ID: 32745482
[TBL] [Abstract][Full Text] [Related]
31. [Abnormal antithrombin III: abnormalities of heparin or protease binding domain].
Sakuragawa N; Niiya K; Takahashi K; Hayashi T; Oguma Y; Saitoh S
Rinsho Byori; 1993 May; 41(5):492-505. PubMed ID: 8350512
[TBL] [Abstract][Full Text] [Related]
32. The John Charnley Award: heritable thrombophilia and development of thromboembolic disease after total hip arthroplasty.
Salvati EA; Della Valle AG; Westrich GH; Rana AJ; Specht L; Weksler BB; Wang P; Glueck CJ
Clin Orthop Relat Res; 2005 Dec; 441():40-55. PubMed ID: 16330983
[TBL] [Abstract][Full Text] [Related]
33. Deficiencies of antithrombin, protein C and protein S - practical experience in genetic analysis of a large patient cohort.
Caspers M; Pavlova A; Driesen J; Harbrecht U; Klamroth R; Kadar J; Fischer R; Kemkes-Matthes B; Oldenburg J
Thromb Haemost; 2012 Aug; 108(2):247-57. PubMed ID: 22627591
[TBL] [Abstract][Full Text] [Related]
34. [Hereditary antithrombin deficiency resulting in severe neonatal thrombosis].
Niklassen US; Ingerslev J; Birkebaek NH
Ugeskr Laeger; 2000 Nov; 162(45):6081-2. PubMed ID: 11107947
[TBL] [Abstract][Full Text] [Related]
35. Foetal growth restriction in children with prothrombotic risk factors.
von Kries R; Junker R; Oberle D; Kosch A; Nowak-Göttl U
Thromb Haemost; 2001 Oct; 86(4):1012-6. PubMed ID: 11686317
[TBL] [Abstract][Full Text] [Related]
36. Clinical presentation and molecular basis of congenital antithrombin deficiency in children: a cohort study.
Kumar R; Chan AK; Dawson JE; Forman-Kay JD; Kahr WH; Williams S
Br J Haematol; 2014 Jul; 166(1):130-9. PubMed ID: 24684277
[TBL] [Abstract][Full Text] [Related]
37. Genetic analysis in Japanese kindreds of congenital type I antithrombin deficiency causing thrombosis.
Nakahara Y; Tsuji H; Nakagawa K; Masuda H; Kitamura H; Nishimura H; Kasahara T; Sugano T; Sawada S; Nakagawa M
Thromb Haemost; 1997 Apr; 77(4):616-9. PubMed ID: 9134630
[TBL] [Abstract][Full Text] [Related]
38. [Thrombophilia in a patient with congenital deficiency of AT III].
Miljić P; Colović M; Stanojević M; Elezović I; Bosković D
Srp Arh Celok Lek; 1994; 122(11-12):344-6. PubMed ID: 17974415
[TBL] [Abstract][Full Text] [Related]
39. Arterial thrombosis in homozygous antithrombin deficiency.
Olivieri M; Bidlingmaier C; Schetzeck S; Borggräfe I; Geisen C; Kurnik K
Hamostaseologie; 2012; 32 Suppl 1():S79-82. PubMed ID: 22961244
[TBL] [Abstract][Full Text] [Related]
40. Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency.
Navarro-Fernández J; de la Morena-Barrio ME; Padilla J; Miñano A; Bohdan N; Águila S; Martínez-Martínez I; Sevivas TS; de Cos C; Fernández-Mosteirín N; Llamas P; Asenjo S; Medina P; Souto JC; Overvad K; Kristensen SR; Corral J; Vicente V
Thromb Haemost; 2016 Jul; 116(1):146-54. PubMed ID: 27098529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
